S 113
118th Congress
Senate
Commerce
Business ethics
Business records
Competition and antitrust
Congressional oversight
Consumer affairs
Health care costs and insurance
Health information and medical records
Inflation and prices
Prescription drugs
Retail and wholesale trades
Prescription Pricing for the People Act of 2023
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 1, 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.
Mar 1, 2023
Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
Feb 9, 2023
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jan 26, 2023
Read twice and referred to the Committee on the Judiciary.
Jan 26, 2023
Introduced in Senate
Plain-English summary
Prescription Pricing for the People Act of 2023
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.
Committees of jurisdiction
1